Toggle navigation
About
Abstract
Editorial Board
Publication Schedule
Subscription & Newsletter
Contact
Issues
This issue
25-1
All issues
Download PDF
Download EPUB
Editor's Selection
This issue
25-1
Browse by topic
Browse by contributor
Dialogue & Opinion
Abstracts
Abstracts
Search
Classification List
Abstracted Journals
Index of Authors
News & Reports
Home
Abstracts
Index of Authors
Author #32644
advertisement
Xia X
13
Showing records 1 to 13 |
Display all abstracts from
Xia X
123554
Reversal of injury-associated retinal ganglion cell gene expression by a phosphodiesterase anchoring disruptor peptide
Zhu Y
Experimental Eye Research
2024; 246: 110017
120382
Self-Assembly Hypoxic and ROS Dual Response Nano Prodrug as a New Therapeutic Approach for Glaucoma Treatments
Zhou X
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
2024; 11: e2407043
123554
Reversal of injury-associated retinal ganglion cell gene expression by a phosphodiesterase anchoring disruptor peptide
Nair RV
Experimental Eye Research
2024; 246: 110017
120382
Self-Assembly Hypoxic and ROS Dual Response Nano Prodrug as a New Therapeutic Approach for Glaucoma Treatments
Rong R
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
2024; 11: e2407043
123554
Reversal of injury-associated retinal ganglion cell gene expression by a phosphodiesterase anchoring disruptor peptide
Xia X
Experimental Eye Research
2024; 246: 110017
120382
Self-Assembly Hypoxic and ROS Dual Response Nano Prodrug as a New Therapeutic Approach for Glaucoma Treatments
Liang G; Wu Y
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
2024; 11: e2407043
123554
Reversal of injury-associated retinal ganglion cell gene expression by a phosphodiesterase anchoring disruptor peptide
Nahmou M
Experimental Eye Research
2024; 246: 110017
120382
Self-Assembly Hypoxic and ROS Dual Response Nano Prodrug as a New Therapeutic Approach for Glaucoma Treatments
Xu C
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
2024; 11: e2407043
123554
Reversal of injury-associated retinal ganglion cell gene expression by a phosphodiesterase anchoring disruptor peptide
Li X; Yan W
Experimental Eye Research
2024; 246: 110017
120382
Self-Assembly Hypoxic and ROS Dual Response Nano Prodrug as a New Therapeutic Approach for Glaucoma Treatments
Xiao H; Ji D
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
2024; 11: e2407043
123554
Reversal of injury-associated retinal ganglion cell gene expression by a phosphodiesterase anchoring disruptor peptide
Li J; Tanasa B
Experimental Eye Research
2024; 246: 110017
120382
Self-Assembly Hypoxic and ROS Dual Response Nano Prodrug as a New Therapeutic Approach for Glaucoma Treatments
Xia X
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
2024; 11: e2407043
123554
Reversal of injury-associated retinal ganglion cell gene expression by a phosphodiesterase anchoring disruptor peptide
Goldberg JL; Kapiloff MS
Experimental Eye Research
2024; 246: 110017
Issue
25-1
Table of Contents
Editor's Selection
PDF
EPUB
Change Issue
26-1
25-4
25-3
25-2
25-1
24-4
24-3
24-1/2
23-4
23-3
23-2
23-1
22-4
22-3
22-2
22-1
21-4
21-3
21-2
21-1
20-4
20-3
20-2
20-1
19-4
19-3
19-2
19-1
18-4
18-3
18-2
18-1
17-4
17-3
17-2
17-1
16-4
16-3
16-2
16-1
15-4
15-3
15-2
15-1
14-4
14-3
14-2
14-1
13-4
13-3
13-2
13-1
12-4
12-3
12-2
12-1
11-4
11-3
11-2
11-1
10-4
10-3
10-2
10-1
9-4
9-3
9-2
9-1
8-4
8-3
8-2
8-1
7-3
7-2
7-1
6-3
6-2
6-1
5-3
5-2
5-1
4-3
4-2
4-1
3-3
3-2
3-1
2-3
2-2
2-1
1-3
1-2
1-1
advertisement
We would like to use Google Analytics to see which parts of the review are read. It is only used to count visits, never for advertising.
Privacy statement
Decline
Accept